VALBIOTIS (EPA:ALVAL) | WebDisclosure

Basculer en Français

9480	Companies
185531	Keywords
117919	Articles
99374	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 06/20/2024 at 08:50, 1 year 5 months ago

Valbiotis : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Mai 2024
Rapport mensuel sur le nombre total d'actions et de droits de vote de Valbiotis conforme à l'article 223-16 du RG de l'AMF. Valbiotis, laboratoire français spécialisé en compléments alimentaires pour la santé cardiovasculaire

Capital Social AMF Valbiotis Compléments Alimentaires Santé Cardiovasculaire
PRESS RELEASE

published on 06/20/2024 at 08:50, 1 year 5 months ago

Valbiotis : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Mai 2024
Valbiotis communique les informations mensuelles sur le nombre de droits de vote et d'actions en mai 2024. L'entreprise est spécialisée dans les compléments alimentaires pour la santé cardiovasculaire

Droits De Vote Capital Social Valbiotis Compléments Alimentaires Troubles Métaboliques
BRIEF

published on 06/17/2024 at 17:45, 1 year 5 months ago

Valbiotis présentera aux sessions de l’American Diabetes Association

Valbiotis Compléments Alimentaires American Diabetes Association TOTUM•63 Diabète
BRIEF

published on 06/17/2024 at 17:45, 1 year 5 months ago

Valbiotis to present at American Diabetes Association sessions

Diabetes Valbiotis American Diabetes Association TOTUM•63 Food Supplements
PRESS RELEASE

published on 06/17/2024 at 17:40, 1 year 5 months ago

Valbiotis sélectionnée aux 84èmes sessions scientifiques de l’American Diabetes Association
Valbiotis sélectionnée pour présenter les résultats cliniques de la Phase II/III REVERSE-IT de TOTUM•63 lors des 84èmes sessions scientifiques de l’American Diabetes Association

Valbiotis Prevention American Diabetes Association TOTUM•63 Diabète De Type 2
PRESS RELEASE

published on 06/17/2024 at 17:40, 1 year 5 months ago

Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results from TOTUM•63 Phase II/III REVERSE-IT study in prediabetes and type 2 diabetes at the American Diabetes Association’s 84th Scientific Sessions

Valbiotis American Diabetes Association TOTUM•63 Clinical Results Scientific Sessions
BRIEF

published on 06/06/2024 at 10:58, 1 year 5 months ago

Valbiotis Terminate Licensing Agreement with Nestlé Health Science

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
BRIEF

published on 06/06/2024 at 10:58, 1 year 5 months ago

Valbiotis met fin à son accord de licence avec Nestlé Health Science

Valbiotis TOTUM•63 Traitement Du Diabète Contrat De Licence Nestlé Sciences De La Santé
PRESS RELEASE

published on 06/06/2024 at 10:53, 1 year 5 months ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis regains full ownership of TOTUM•63, a plant-based dietary supplement for prediabetes and early type 2 diabetes, after terminating agreement with Nestlé Health Science

Valbiotis Dietary Supplement TOTUM•63 Nestlé Health Science Prediabetes
BRIEF

published on 06/06/2024 at 10:49, 1 year 5 months ago

Valbiotis et Nestlé Health Science mettent fin à leur contrat de licence et d’approvisionnement

Valbiotis Compléments Alimentaires Propriété Intellectuelle TOTUM•63 Nestlé

Accesswire

Published on 12/05/2025 at 19:20, 1 minute ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 36 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 1 minute ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 21 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 6 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 23 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 55 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 6 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 29 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 35 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 3 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 3 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 10 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 10 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 22 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE